Support preserving and fully considering the Patent Trial and Appeal Board as an important mechanism for faster, cheaper patent-validity adjudication.

Darrell Issa · California · Republican

oversight impact 2.00 specificity 1.00 extraction confidence 90%

Commitment kind: unknown. Promised action: not established. Promised outcome: not established. Deadline: unknown; not assumed expired.

Contest this claim

Occurrences

Evidence

legacy_unverified · Source version not recorded · locator unknown

Issa said PTAB is an important check for faster, cheaper patent-validity adjudication and urged the USPTO director to fully consider it rather than ignore or cast it aside.

Unverified model/legacy excerpt; not proof. AI summary (separate from source): This is a direct public endorsement from Issa of preserving PTAB and treating it as a useful mechanism for lower-cost, faster patent validity review.

delivered same_term A for effort

Issa notes Trump USPTO achievements, urges utilization of PTAB to achieve Administration’s vision and policy goals | Representative Darrell Issa
primary · model gpt-5.4-mini · confidence 97%

Contest this evidence item

legacy_unverified · Source version not recorded · locator unknown

Issa endorsed PTAB as an important check for faster, cheaper patent-validity adjudication and urged USPTO Director John Squires to fully consider it rather than cast it aside.

Unverified model/legacy excerpt; not proof. AI summary (separate from source): Direct official statement from Issa in his current House term fulfills the support/oversight commitment to preserve and fully consider PTAB.

delivered same_term A for effort

Issa notes Trump USPTO achievements, urges utilization of PTAB to achieve Administration’s vision and policy goals | Representative Darrell Issa
primary · model gpt-5.5 · confidence 97%

Contest this evidence item

legacy_unverified · Source version not recorded · locator unknown

The House Judiciary Subcommittee on Courts, Intellectual Property, Artificial Intelligence, and the Internet held a March 25, 2026 USPTO oversight hearing examining the agency's mission, operations, policies, and related matters.

Unverified model/legacy excerpt; not proof. AI summary (separate from source): This official hearing record corroborates the oversight setting in which Issa, as subcommittee chair, pressed USPTO on PTAB treatment during the same congressional term.

partial same_term A for effort

Oversight of the U.S. Patent and Trademark Office | House Judiciary Committee Republicans
secondary · model gpt-5.5 · confidence 78%

Contest this evidence item

Assessments

Public state: unverified As of unknown · legacy_unverified · . Original AI recommendation (not independently established): delivered. same_term

Issa personally and publicly endorsed PTAB as a faster, cheaper patent-validity adjudication mechanism and urged the USPTO director during his current House term to fully consider and use it rather than cast it aside. Because the promise was to support preservation and consideration, not to enact a statutory change, this official same-term advocacy and oversight activity satisfies the commitment.

provider codex_cli · model gpt-5.5 · confidence 96%

Public state: unverified As of unknown · legacy_unverified · . Original AI recommendation (not independently established): delivered. same_term

The promise is framed as support for preserving and seriously considering the Patent Trial and Appeal Board, not as a requirement to single-handedly enact a final institutional outcome. The cited March 26, 2026 statement shows Darrell Issa publicly argued that PTAB is an important mechanism for faster, cheaper patent-validity review and urged the USPTO director to fully consider and utilize it rather than discard it. That is a direct fulfillment of a support/oversight-style promise during his current federal service, so this counts as delivered in the same term.

provider codex_cli · model gpt-5.4 · confidence 96%

Public state: unverified As of unknown · legacy_unverified · . Original AI recommendation (not independently established): delivered. same_term

Issa publicly endorsed preserving and fully considering the PTAB as a useful, faster and cheaper patent-validity mechanism, which matches the claim. The evidence is a direct statement during his current term, so the promise is satisfied with same-term timing.

provider codex_cli · model gpt-5.4-mini · confidence 96%